This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Sandbox Reserved 452
From Proteopedia
Contents |
C-Myc
|
THIS IS THE OF YOUR PROTEIN.
THIS SHOWS THE IN THE PROTEIN.
-->
Introduction
C-Myc is a transcription factor involved in the cell cycle specifically with the stimulation of cell proliferation but is also involved in the regulation of apoptosis, cell differentiation, cell competition, and senescence [1]. C-Myc is a DNA binding protein and functions primarily by inducing transcription through the formation of heterodimers primarily with Max proteins. C-Myc's interactions are not limited to only Max protiens as it has been shown to interact with BRCA1[2], MAPK1[3], p73[4], and many more. C-Myc is also a protooncogene, and when normally expressed is strictly regulated by signals within the cell cycle, so that when a cell is resting its c-myc expression is little while when growing it expresses high levels of c-myc. When normal cells overexpression of c-myc activates a protection pathway and the abnormal cells are thus eliminated from the host organism through apoptosis, thus protecting the organism.
Structure
The c-myc protein contains two specific regions that characterize them as transcription factors: a carboxy-terminal basix helix-loop-helix leucine zipper motif and an amino terminal transactivation domain[5]. Immediatley following the basic region within the c-myc protein is the helix -loop-helix motif which has been shown to interact with DNA through binding [6]. The c-myc gene is essientially found on human chromosome 8q24 and contains three exons.
Mechanism
Most of the biological functions that c-myc performs involves herterodimerization with Max.
Medical Uses and Therapeutic Opportunities
References
- ↑ Uribesalgo I, Benitah SA, Di Croce L. From oncogene to tumor suppressor: The dual role of Myc in leukemia. Cell Cycle. 2012 May 1;11(9). PMID:22510570
- ↑ Wang Q, Zhang H, Kajino K, Greene MI. BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells. Oncogene. 1998 Oct 15;17(15):1939-48. PMID:9788437 doi:10.1038/sj.onc.1202403
- ↑ Gupta S, Davis RJ. MAP kinase binds to the NH2-terminal activation domain of c-Myc. FEBS Lett. 1994 Oct 24;353(3):281-5. PMID:7957875
- ↑ Watanabe K, Ozaki T, Nakagawa T, Miyazaki K, Takahashi M, Hosoda M, Hayashi S, Todo S, Nakagawara A. Physical interaction of p73 with c-Myc and MM1, a c-Myc-binding protein, and modulation of the p73 function. J Biol Chem. 2002 Apr 26;277(17):15113-23. Epub 2002 Feb 13. PMID:11844794 doi:10.1074/jbc.M111281200
- ↑ Amati B, Land H. Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation and death. Curr Opin Genet Dev. 1994 Feb;4(1):102-8. PMID:8193530
- ↑ Amati B, Land H. Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation and death. Curr Opin Genet Dev. 1994 Feb;4(1):102-8. PMID:8193530
